| ■ 영문 제목 : Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR022
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 100
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Grand View Research사의 본 조사 보고서는 글로벌 정밀 종양학 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 2,020억 달러에 달할 것으로 전망하고 있습니다. 본 자료는 글로벌 정밀 종양학 시장을 조사대상으로 하여, 조사 범위 및 목적, 조사 방법, 개요, 시장 변동/동향/범위, 제품 종류별 (진단제, 치료약) 분석, 암 종류별 (유방암, 대장암, 자궁 경부암, 전립선암, 기타) 분석, 최종 용도별 (병원 및 진단 연구소, 제약 및 바이오테크놀로지 기업, 의료 데이터 기업) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카) 분석, 경쟁 분석 등의 내용을 게재하고 있습니다. 덧붙여 본 리포트는 THERMO FISHER SCIENTIFIC INC., INVITAE CORPORATION, QIAGEN N.V., ILLUMINA, INC., LABORATORY CORPORATION OF AMERICA HOLDING, EXACT SCIENCES CORPORATION 등의 기업 정보가 포함되어 있습니다.
・조사 범위 및 목적
・조사 방법
・개요
・시장 변동/동향/범위
・글로벌 정밀 종양학 시장 규모 : 제품 종류별
- 진단제의 시장 규모
- 치료제의 시장 규모
・글로벌 정밀 종양학 시장 규모 : 암 종류별
- 유방암에 사용되는 정밀 종양학의 시장 규모
- 대장암에 사용되는 정밀 종양학의 시장 규모
- 자궁 경부암에 사용되는 정밀 종양학의 시장 규모
- 전립선암에 사용되는 정밀 종양학의 시장 규모
- 기타 암에 사용되는 정밀 종양학의 시장 규모
・글로벌 정밀 종양학 시장 규모 : 최종 용도별
- 병원 및 진단 연구소에서 사용되는 정밀 종양학의 시장 규모
- 제약 및 바이오테크놀로지 기업에서 사용되는 정밀 종양학의 시장 규모
- 의료 데이터 기업에서 사용되는 정밀 종양학의 시장 규모
・글로벌 정밀 종양학 시장 규모 : 지역별
- 북미의 정밀 종양학 시장 규모
- 유럽의 정밀 종양학 시장 규모
- 아시아 태평양의 정밀 종양학 시장 규모
- 중남미의 정밀 종양학 시장 규모
- 중동과 아프리카의 정밀 종양학 시장 규모
・경쟁 분석 |
■ 보고서 개요Precision Oncology Market Growth & Trends
The global precision oncology market size is expected to reach USD 202.0 billion and expand at a CAGR of 9.7% from 2023 to 2030, based on a new report by Grand View Research, Inc. Precision oncology is a growing field where the market products emphasize on molecular profiling of tumors to identify alterations in the gene. Currently, the industry has witnessed major success with a 95% response rate being observed in patients along with extended quality-adjusted life. The market products offer the potential for improved patient care and a better-informed decision-making experience in hospitals and clinics. Alternatively, the increasing prevalence of cancer across the globe, the rising number of clinical trial studies, and the rapid adoption of technology in precision oncology diagnostic is anticipated to boost the market demand.
Due to the COVID-19 pandemic, the precision oncology market had a huge impact as the pandemic exaggerated healthcare across the globe for people living with cancer, possessing a unique set of challenges. Besides, delayed diagnosis and therapeutics using precision oncology have affected cancer patient diagnosis and treatment to a major extent. However, post-COVID-19 pandemic, the market has gained rapid demand as precision oncology offers better therapeutic outcomes and improves the quality of patient life for cancer patients.
In January 2022, OncXerna Therapeutics, Inc. and Exact Sciences Corp. mentioned the agreement to introduce OncXerna’s TME Panel lab services for patients in the U.S. It is an innovative gene expression score, which helps identify patients to respond to immunotherapies and anti-angiogenic. Further, the company added that it believes to provide clinician access to the Xerna TME Panel through biopharma partners as a companion diagnostic and existing precision oncology team.
Precision Oncology Market Report Highlights
• Based on product type, the therapeutics segment held the majority of the market share of around 71.7% in 2022 attributed to its rising number of approvals of therapies has benefited the market demand
• Based on cancer type, the breast cancer segment dominated the market in terms of revenue share in 2022 owing to the rising incidence of breast cancer, expanding research activities, evolved diagnostics, and overall patient prognosis is likely to drive the market
• Based on end-use, the hospitals & clinics segment accounted for the largest market share of around 46.8% in 2022 owing to the growing focus on components such as precision planning, precise diagnosis and monitoring, precise treatment
• In 2022, North America dominated the market in terms of revenue with a share of around 42.5% due to trending factors such as rising healthcare expenditure, and evolving healthcare landscape, changing competitive landscape of the precision oncology market in U.S. and Canada
■ 보고서 목차Table of Contents
Chapter 1 Report Scope and Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective – 1
1.3.2 Objective – 2
1.3.3 Objective – 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Gvr’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product Type
3.2.2 Cancer Type
3.2.3 End-Use
3.2.4 Region
3.3 Competitive Insights
3.4 Precision Oncology Market Outlook, 2020
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook
4.2 Precision Oncology Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Precision Oncology Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.2 Threat Of New Entrants
4.3.3 Bargaining Power Of Suppliers
4.3.4 Bargaining Power Of Buyers
4.3.5 Competitive Rivalry
4.3.6 Threat Of Substitutes
4.3.7 Pestel Analysis
4.3.7.1 Political & Legal Landscape
4.3.7.2 Economic Landscape
4.3.7.3 Technological Landscape
4.4 Penetration & Growth Prospect Mapping
4.5 Impact Of Covid-19 On Precision Oncology Market
Chapter 5 Precision Oncology Market: Product Type Analysis
5.1 Precision Oncology Market Share Analysis, 2020 & 2028
5.2 Precision Oncology Market: Segment Dashboard:
5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Type Segment
5.3.1 Diagnostics
5.3.1.1 Diagnostics Market, 2018 – 2030 (USD Million)
5.3.2 Therapeutics
5.3.2.1 Therapeutics Market, 2018 – 2030 (USD Million)
Chapter 6 Precision Oncology Market: Cancer Type Analysis
6.1 Precision Oncology Cancer Type Market Share Analysis, 2020 & 2028
6.2 Precision Oncology Cancer Type Market: Segment Dashboard:
6.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Cancer Type Segment
6.3.1 Breast Cancer
6.3.1.1 Breast Cancer Market, 2018 – 2030 (USD Million)
6.3.2 Colorectal Cancer
6.3.2.1 Colorectal Cancer Market, 2018 – 2030 (USD Million)
6.3.3 Cervical Cancer
6.3.4 Cervical Cancer Market, 2018 – 2030 (USD Million)
6.3.5 Prostate Cancer
6.3.5.1 Prostate Cancer Market, 2018 – 2030 (USD Million)
6.3.6 Lung Cancer
6.3.6.1 Lung Cancer Market, 2018 – 2030 (USD Million)
6.3.7 Others Cancer
6.3.7.1 Others Cancer Market, 2018 – 2030 (USD Million)
Chapter 7 Precision Oncology Market: End-Use Analysis
7.1 Precision Oncology End-Use Market Share Analysis, 2020 & 2028
7.2 Precision Oncology End-Use Market: Segment Dashboard:
7.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The End-Use Segment
7.3.1 Hospitals & Diagnostic Laboratories
7.3.2 Hospitals & Diagnostic Laboratories Market, 2018 – 2030 (USD Million)
7.3.3 Pharmaceutical & Biotechnology Companies
7.3.3.1 Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
7.3.4 Healthcare Data Companies
7.3.5 Healthcare Data Companies Market, 2018 – 2030 (USD Million)
Chapter 8 Precision Oncology Market: Regional Analysis
8.1 Precision Oncology Regional Market Share Analysis, 2020 & 2028
8.2 Regional Market Snapshot
8.3 North America
8.3.1 North America Precision Oncology Market, 2018 – 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Precision Oncology Market, 2018 – 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Precision Oncology Market, 2018 – 2030 (USD Million)
8.4 Europe
8.4.1 Europe Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.3 Germany
8.4.3.1 Germany Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.4 France
8.4.4.1 France Precision Oncology Market, 2018 – 2030 (USD MILLION)
8.4.5 Italy
8.4.5.1 Italy Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.7 Denmark
8.4.8 Denmark Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.9 Sweden
8.4.10 Sweden Precision Oncology Market, 2018 – 2030 (USD Million)
8.4.11 Norway
8.4.12 Norway Precision Oncology Market, 2018 – 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Japan Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.3 China
8.5.3.1 China Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.4 India
8.5.4.1 India Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.5 Australia
8.5.5.1 Australia Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.6 Thailand
8.5.7 Thailand Precision Oncology Market, 2018 – 2030 (USD Million)
8.5.8 South Korea
8.5.8.1 South Korea Precision Oncology Market, 2018 – 2030 (USD Million)
8.6 Latin America
8.6.1 Latin America Precision Oncology Market, 2018 – 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Brazil Precision Oncology Market, 2018 – 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Mexico Precision Oncology Market, 2018 – 2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Argentina Precision Oncology Market, 2018 – 2030 (USD Million)
8.7 Middle East And Africa (Mea)
8.7.1 Mea Precision Oncology Market, 2018 – 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Precision Oncology Market, 2018 – 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Precision Oncology Market, 2018 – 2030 (USD Million)
8.7.4 UAE
8.7.4.1 UAE Precision Oncology Market, 2018 – 2030 (USD Million)
8.7.5 Kuwait
8.7.6 Kuwait Precision Oncology Market, 2018 – 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Profiles
9.2.1 THERMO FISHER SCIENTIFIC INC.
9.2.1.1 Company overview
9.2.1.2 Financial performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic initiatives
9.2.2 INVITAE CORPORATION
9.2.2.1 Company overview
9.2.2.2 Product Benchmarking
9.2.2.3 Strategic initiatives
9.2.3 QIAGEN N.V.
9.2.3.1 Company overview
9.2.3.2 Product Benchmarking
9.2.3.3 Strategic initiatives
9.2.4 ILLUMINA, INC.
9.2.4.1 Company overview
9.2.4.2 Product Benchmarking
9.2.4.3 Strategic initiatives
9.2.5 LABORATORY CORPORATION OF AMERICA HOLDING
9.2.5.1 Company overview
9.2.5.2 Product Benchmarking
9.2.5.3 Strategic initiatives
9.2.6 EXACT SCIENCES CORPORATION
9.2.6.1 Company overview
9.2.6.2 Product Benchmarking
9.2.6.3 Strategic initiatives
9.2.7 RAIN ONCOLOGY INC.
9.2.7.1 Company overview
9.2.7.2 Product Benchmarking
9.2.7.3 Strategic initiatives
9.2.8 STRATA ONCOLOGY, INC.
9.2.8.1 Company overview
9.2.8.2 Product Benchmarking
9.2.8.3 Strategic initiatives
9.2.9 XILIS, INC.
9.2.9.1 Company overview
9.2.9.2 Product Benchmarking
9.2.9.3 Strategic initiatives
9.2.10 VARIANTYX, INC.
9.2.10.1 Company overview
9.2.10.2 Product Benchmarking
9.2.10.3 Strategic initiatives
9.2.11 BIOSERVE
9.2.11.1 Company overview
9.2.11.2 Product Benchmarking
9.2.11.3 Strategic initiatives
9.2.12 RELAY THERAPEUTICS
9.2.12.1 Company overview
9.2.12.2 Product Benchmarking
9.2.12.3 Strategic initiatives
9.2.13 ACRIVON THERAPEUTICS
9.2.13.1 Company overview
9.2.13.2 Product Benchmarking
|
| ※본 조사보고서 [세계의 정밀 종양학 시장 (2023-2030) : 제품 종류별 (진단제, 치료제), 암 종류별 (유방암, 자궁 경부암, 전립선암, 폐암), 최종 용도별, 지역별] (코드 : GRV23MR022) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 정밀 종양학 시장 (2023-2030) : 제품 종류별 (진단제, 치료제), 암 종류별 (유방암, 자궁 경부암, 전립선암, 폐암), 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
